Stay updated on Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T12:10:06.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T09:41:55.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The website has removed a detailed section regarding data download options and study information fields, which may affect users looking for specific data formats and study details.
    Difference
    13%
    Check dated 2024-11-22T18:57:55.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Several key government health and information websites have been removed from the monitored list.
    Difference
    0.7%
    Check dated 2024-11-15T13:28:38.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new resource links and enhancing the data download options, while the previous version 2.12.1 has been removed.
    Difference
    17%
    Check dated 2024-11-08T12:41:46.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.0 to v2.12.1.
    Difference
    0.3%
    Check dated 2024-11-01T10:15:21.000Z thumbnail image

Stay in the know with updates to Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.